CYTK
Cytokinetics (CYTK)
NASDAQ
$79.91-$0.11 (-0.13%)
Price as of Jun 23, 2026 7:30 PM EDT
  • $10.7B
    Market Cap
  • 142.56%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
8.7M
-52.98%
18.5M
+145.34%
7.5M
-92.04%
94.6M
+34.30%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
8.7M
-52.98%
18.5M
+145.34%
7.5M
-92.04%
94.6M
+34.30%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-416.0M
+22.57%
-339.4M
+2.81%
-330.1M
+37.09%
-240.8M
+50.57%
Depreciation and Amortization Expense
10.1M
+6.23%
9.5M
-19.85%
11.9M
+104.54%
5.8M
+155.45%
Total Operating Expenses
700.3M
+26.24%
554.7M
+10.12%
503.7M
+20.28%
418.8M
+63.12%
Operating Profit
-612.3M
+14.17%
-536.2M
+8.07%
-496.2M
+53.05%
-324.2M
+74.01%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
11.4M
+1,040.00%
Interest Expense
-45.6M
+20.90%
-37.7M
+33.19%
-28.3M
+45.80%
-19.4M
+18.09%
Interest Income and Expense and Net
-45.6M
+20.90%
-37.7M
+33.19%
-28.3M
+253.21%
-8.0M
-48.10%
Total Nonoperating Income and Expense
48.4M
-6.04%
51.5M
+86.52%
27.6M
+143.60%
11.3M
+3,326.59%
Income before Taxes
-612.3M
+14.17%
-536.2M
+8.07%
-496.2M
+53.05%
-324.2M
+74.01%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-785.0M
+33.15%
-589.5M
+12.03%
-526.2M
+35.30%
-389.0M
+80.65%
Net Income from Continuing Operations Applicable to Common
-785.0M
+33.15%
-589.5M
+12.03%
-526.2M
+35.30%
-389.0M
+80.65%
Basic EPS and Net Income
-6.54
+24.33%
-5.26
-3.49%
-5.45
+25.87%
-4.33
+54.64%
Diluted EPS and Net Income
-6.54
+24.33%
-5.26
-3.49%
-5.45
+25.87%
-4.33
+54.64%
Basic Weighted Average Shares
120,103
+7.25%
111,979
+16.01%
96,524
+7.46%
89,825
+16.83%
Diluted Weighted Average Shares
120,103
+7.25%
111,979
+16.01%
96,524
+7.46%
89,825
+16.83%
Balance Sheet
Cash and Cash Equivalents
122.5M
+29.16%
94.9M
-16.07%
113.0M
+72.34%
65.6M
-41.79%
Short-Term Investments
759.7M
-22.57%
981.2M
+95.53%
501.8M
-30.01%
717.0M
+99.74%
Cash and Cash Equivalents and Short-Term Investments
882.2M
-18.01%
1.1B
+75.01%
614.8M
-21.44%
782.6M
+65.93%
Total Current Assets
917.0M
-17.24%
1.1B
+76.41%
628.1M
-21.02%
795.2M
+48.45%
Accumulated Depreciation
47.3M
+27.23%
37.2M
+31.15%
28.3M
+65.84%
17.1M
+5.59%
Property and Plant and Equipment and Net
79.2M
+20.33%
65.8M
-4.27%
68.7M
-14.55%
80.5M
+9.80%
Total Long-Term Assets
17.3M
+125.06%
7.7M
-3.64%
8.0M
-17.49%
9.7M
+34.82%
Total Assets
1.4B
+1.63%
1.4B
+70.04%
824.3M
-18.77%
1.0B
+20.62%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
41.2M
+257.47%
11.5M
+14.29%
10.1M
N/A
N/A
N/A
Total Current Liabilities
202.5M
+12.68%
179.7M
+74.99%
102.7M
+21.34%
84.6M
+17.75%
Total Long-Term Debt
246.4M
+164.28%
93.2M
+59.68%
58.4M
-8.50%
63.8M
+34.71%
Total Long-Term Liabilities
354.4M
N/A
0
-100.00%
186,000
-82.18%
1.0M
-76.58%
Total Liabilities
2.1B
+35.60%
1.5B
+26.96%
1.2B
+7.84%
1.1B
+87.91%
Retained Earnings
-3.5B
+29.05%
-2.7B
+27.91%
-2.1B
+33.18%
-1.6B
+31.33%
Total Stockholders Equity
-659.6M
+387.27%
-135.4M
-64.96%
-386.3M
+258.04%
-107.9M
-144.25%
Total Shares Outstanding
122.9M
+4.00%
118.2M
+16.30%
101.6M
+7.17%
94.8M
+11.83%
Cash Flow
Cash from Operating Activities
-510.0M
+28.83%
-395.9M
-4.45%
-414.3M
+38.33%
-299.5M
+110.15%
Capital Expenditures
24.8M
+535.10%
3.9M
+175.85%
1.4M
-87.51%
11.3M
-76.81%
Cash from Investing Activities
16.7M
+103.01%
-553.1M
-331.18%
239.3M
+191.27%
-262.1M
+77.38%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
524.5M
-43.64%
930.6M
+320.49%
221.3M
-57.12%
516.2M
+61.31%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-7,048.79%
+142.83%
-2,902.72%
-55.95%
-6,589.71%
+1,822.59%
-342.75%
+29.56%
Return on Assets
-55.55%
+4.87%
-52.97%
-7.45%
-57.23%
+36.55%
-41.91%
+33.83%
Return on Equity
197.47%
-12.62%
226.00%
+6.13%
212.96%
+137.22%
-572.15%
+374.65%
Revenue Growth
-52.98%
-136.45%
145.34%
+257.91%
-92.04%
-368.30%
34.30%
+31.17%
Current Ratio
4.53
-26.55%
6.17
+0.81%
6.12
-34.91%
9.40
+26.07%
Cash Ratio
0.61
+14.64%
0.53
-52.04%
1.10
+42.04%
0.78
-50.57%
Debt-to-Equity Ratio
-0.44
-43.65%
-0.77
+336.68%
-0.18
N/A
N/A
N/A
Debt-to-Assets Ratio
0.20
+170.28%
0.07
-10.11%
0.08
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow